SCHEMBL25760174

SCHEMBL25760174

Cc1ccc(Cc2nc3c(Cc4ccccc4)[nH]c(-c4cccc(O)c4)cn-3c2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASR P41180 1/20 0.38
▸ IDH1 O75874 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ ALKBH3 Q96Q83 2/20 0.36
▸ MMP9 P14780 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ GABRA1 P14867 1/20 0.34
▸ GABRB2 P47870 1/20 0.34
▸ MAT2A P31153 1/20 0.34
▸ CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21751336 0.94 ADORA3 (0.41) CASRADORA3ADORA2AADORA1ALDH1A1
SCHEMBL25760179 0.94 CASR (0.39) CASRIDH1ADORA3ADORA2AADORA1
SCHEMBL21751454 0.93 ADORA3 (0.39) CASRADORA3ADORA2AADORA1ALDH1A1
SCHEMBL30800148 0.93 ADORA3 (0.39) CASRADORA3ADORA2AADORA1ALDH1A1
SCHEMBL21751359 0.91 ADORA3 (0.37) CASRADORA3ADORA2AADORA1ALDH1A1
SCHEMBL25760164 0.91 ADORA3 (0.37) CASRADORA3ADORA2AADORA1ALDH1A1
SCHEMBL17407642 0.90 ALKBH3 (0.38) ALDH1A1ALKBH3MMP9MAOAMAOB
SCHEMBL21751461 0.90 KDM4E (0.41) ADORA3ALDH1A1GAAMEN1KMT2A
SCHEMBL10196888 0.89 ABCB1 (0.39) ADORA3ADORA1ALDH1A1ALKBH3MMP9
SCHEMBL20841761 0.89 ABCB1 (0.39) ADORA3ADORA1ALDH1A1ALKBH3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691976-B2 Coelenterazine analogues GLB1, SI, TCF7L2 CASR 2864/4885IDH1 3282/4885ADORA3 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback